Return to homepagePandemic Pact

DF-AMR.2: Gene-based reversal of antibiotic resistance within complex bacterial communities (GENDARM) - Development of phage-driven CRISPR/Cas systems

  • Funded by Federal Ministry of Research, Technology and Space (BMFTR)
  • Total publications:1 publications

Grant number: 01KI2133

Grant search

Key facts

  • Disease

    N/A

  • Start & end year

    2021
    2023

  • Known Financial Commitments (USD)

    $521,541.62

  • Funder

    Federal Ministry of Research, Technology and Space (BMFTR)

  • Principal Investigator

    N/A

  • Research Location

    Germany

  • Lead Research Institution

    Universitätsklinikum Aachen

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen genomics, mutations and adaptations

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

N/A

1 Publication linked via Europe PMC

Last Updated:6 days ago

View all publications at Europe PMC

Newly isolated Drexlerviridae phage LAPAZ is physically robust and fosters eradication of Klebsiella pneumoniae in combination with meropenem.